evaluate the health and wellness company biotrust nutrition on glp-1 Support GLP-1 Support
Description
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
Average cost-sharing for a one-month supply of GLP-1 medications ranged from $61 to $93 in 2023
For dieters and people who just want to lose a little weight new drugs on the market are giving consumers a choice
Understanding who may be at higher riskbased on medical history, biomarkers, and genetic predispositionscan help patients and providers make more informed treatment decisions
